(Total Views: 283)
Posted On: 07/02/2018 8:13:22 PM
Post# of 72447
Q3 Potential Milestones
1. B-OM - Breakthrough Therapy Designation
2. Prurisol - Top-line Data (Phase 2b)
3. Licensing Agreement (double-digits millions upfront payment)
http://www.ipharminc.com/press-release/2018/6...re-capital
1. B-OM - Breakthrough Therapy Designation
2. Prurisol - Top-line Data (Phase 2b)
3. Licensing Agreement (double-digits millions upfront payment)
http://www.ipharminc.com/press-release/2018/6...re-capital
(0)
(0)
